Josh LehrerFounder

United States - Palo Alto, California

- Proven strategic leader in both large biopharma environment and in fast-paced biotech startup environments
- Track record building and leading a highly functioning development organization developing multiple programs (large and small molecules)
- Program and clinical/regulatory leadership from pre-IND through NDA approval and successful commercial launch, including negotiation of novel registrational endpoints, accelerated approval, breakthrough designation and rare disease experience.
- Leadership role in board and investor interactions, including supporting successful initial public offering, multiple highly successful financings and podium presentations at multiple finance conferences.
- As member of Senior Management Team, experience in building a biotech company from pre-IND/series A through 4+ billion market cap and NDA.
- Business development experience leading cross-functional team to evaluate in-licensing opportunities, led successful in-licensing of Phase 3 asset
- Basic science and translational experience in cardiovascular biology, active clinical practice in cardiology

Specialties: Board certified in internal medicine, cardiovascular medicine and nuclear cardiology.